M3USA

About M3: A Japanese global leader in the provision of ground-breaking and innovative technological and research solutions to the healthcare industry. The M3 Group operates in the US, Asia, and Europe with over 5.8 million physician members globally via its physician websites which include mdlinx.com, m3.com, research.m3.com, Doctors.net.uk, medigate.net, and medlive.cn. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413, NIKKEI 225) with subsidiaries in major markets including the US, UK, Japan, South Korea, and China, and in 2020 was ranked in Forbes’ Global 2000 list. The M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Japan, UK, France, Germany, Brazil, Sweden, China, USA, and South Korea, as well as India. About the Business Unit: M3 EU delivers market research and healthcare technology services to large pharmaceutical clients across Europe. Based within M3 EU Central Services, this role owns M3's global sustainability compliance programme end to end - spanning EcoVadis performance, carbon and emissions reporting, supplier and procurement due diligence, and sustainability governance and policy across M3's business units - ensuring our credentials and supporting documentation stand up to scrutiny during Master Services Agreement (MSA) negotiations, contract renewals and client questionnaires.